Objective: Recent data suggest that the low thyroid function syndrome in depression is nonspecific. They also suggest that depression may constitute a risk factor for the development of dementia, especially in atypical patients who have high rates of hypothalamo-pituitary-adrenal axis disorders. This study aimed to search for correlations among Dexamethasone Suppression Test (DST) cortisol levels, thyroid indices, and family history of dementia in patients with depression.
S everal risk factors have been proposed for the developdementia of the Alzheimer type (3) . ment of Alzheimer's disease (AD), among them, a family history of dementia (1) and prior thyroid disease (2) . The
The present study searched for correlations among results of a recent case-control study from Greece suggested Dexamthasone Suppression Test (DST) cortisol levels, thythat depression, when combined with a family history of roid indices, and family history of dementia in depression The comparison was made with 1-way multiple analysis of covariance (Wilks' 8= 0.371; Rao's R = 3.048; df 10,18; P = 0.019), with age as a covariate. The P values are for post hoc t tests used to evaluate differences between families with and without a history of dementia.
patients. To our knowledge, this is the first study that explores this possible relation.
Material and Methods
Thirty patients entered the study. There were 10 men and 20 women (mean age 42.43 years, SD 11.82 years; range 21 to 60 years). All suffered from major depressive disorder diagnosed according to DSM-IV criteria. All had been free of any medi cation for at least 2 weeks prior to entering the study. They were physically healthy, with normal clinical and laboratory findings (specifically, EEG, blood and biochemical testing, and testing for pregnancy, B12, and folic acid).
All patients provided written informed consent before partici pating in the study. The hospital's investigational review board approved the protocol. We used the Schedule for Clini cal Assessment in Neuropsychiatry, Version 2.0 (4,5), and the International Personality Disorders Examination (6-9) for clinical diagnosis. Data concerning the family history of dementia of any kind were registered according to the family history method (10) .
Assessment of Thyroid Function
We assessed serum levels of free T3 (FT3), free T4 (FT4), thyroid-stimulating hormone (TSH), thyroid-binding inhibi tory immunoglobulines (TBII), thyroglobulin antibodies (TAs), and thyroid microsomal antibodies (TMAs) for all patients. We also calculated the FT4/FT3 ratio. Table 1 shows the technical details of the measurement methods.
The Dexamethasone Suppression Test
The DST (11) protocol demands the oral administration of 1 mg dexamethasone at 23.00 hours on the first day and deter mination of cortisol serum levels simultaneously and on the following day at 16.00 and 23.00 hours. Cortisol levels (in mg/dL) were measured by luminance immunoassay (intraassay reliability, 4.9%; interassay reliability, 7.5%). The nonsuppression cut-off level was 5 mg/dL cortisol.
The statistical analysis included 1-way multiple analysis of covariance with age as the covariate and t test as the post hoc test.
Results
Three patients (10%) had a family history of dementia and manifested significantly higher TMA levels (P < 0.001, see 
Discussion
Many authors suggest that depression may be characterized by a "low thyroid function syndrome" (12) (13) (14) . However, screening tests are often routinely applied for inpatients with depression, and data suggest that thyroid screening adds little to the diagnostic evaluation.
Concerning the hypothalamo-pituitary-thyroid axis, Musselman and Nemeroff (15) have reported that patients suffering from depression show altered TSH response to thyrotropin-releasing hormone (TRH), an abnormally high rate of antithyroid antibodies, and elevated TRH concentra tions in cerebrospinal fluid. Moreover, triiodothyronine has been shown conclusively to augment the efficacy of various antidepressants (16) .
Other authors report that autoimmune thyroiditis associated with a mild subclinical form of hypothyroidism is more pro nounced in patients with AD. There are also direct reports that high values of antithyroglobulin and antimicrosomial autoantibodies are present in AD patients (17) .
Our study reports that, while serum levels of FT3, FT4, and TSH are generally within the normal range in patients suffer ing from depression, significantly higher thyroid microsomal antibodies (TMAs) were present in patients having a positive family history of dementia.
Microsomal antibodies are frequently present in patients with chronic lymphocytic thyroiditis, while thyroid-binding inhib itory immunoglobulines inhibit the binding of TSH to its receptor and lead to hypothyroidism.
The main advantage of our study was the deep and thorough clinical and laboratory investigation of patients who consti tuted a natural population. Its major disadvantage was the small number of patients in the group with a positive family history of dementia.
Conclusion
The current study confirms that overt thyroid dysfunction is not common in depression patients. However, an autoimmune process may characterize a subgroup of patients, and this pro cess may be even more pronounced in patients with a family history of dementia. In patients suffering from depression, the mechanism that could relate the severity of an autoimmune process to family history of dementia remains unknown. Résultats : Des niveaux significativement plus élevés d'AMT ont été trouvés chez les patients ayant des antécédents familiaux de démence, comparativement à ceux qui n'avaient pas ces antécédents.
Conclusion :
Les résultats de la présente étude suggèrent qu'un processus auto-immun plus prononcé peut caractériser la dépression chez les patients ayant des antécédents familiaux de démence.
